Executive Bio
Dr. Sergey Kipriyanov serves as Head of Research and Development of Affimed Therapeutics B.V. Dr. Kipriyanov serves as Group leader at the Institute of Molecular Biology, Novosibirsk and Member of the research group, Recombinant Antibodies at the DKFZ, Heidelberg. Dr. Kipriyanov holds Ph.D. at the Institute of Genetics and Selection of Industrial Microorganisms, Moscow. Dr. Kipriyanov is a Molecular Biologist.